Literature DB >> 1709598

Creatine metabolism during metabolic perturbations in patients with organic acidurias.

S E Davies1, R A Iles, T E Stacey, R A Chalmers.   

Abstract

Creatine excretion was measured in two patients with methylmalonic aciduria and two patients with 3-hydroxy-3-methylglutaric aciduria. During periods of metabolic decompensation the creatine/creatinine ratio increased and fell during recovery. Prolonged periods of metabolic decompensation may result in the loss of a large proportion of the creatine pool. In one study, measurements of total daily urinary output of metabolites demonstrated that the absolute creatine excretion followed a similar qualitative pattern to the creatine/creatinine ratio. However, apparent fluctuations in methylmalonate excretion when expressed as methylmalonate/creatinine ratio were absent when absolute methylmalonate excretion was calculated. The increased creatine excretion during metabolic perturbations may result from loss from creatine containing tissues such as muscle and may represent an underlying defect in energy metabolism. Alternatively creatine transport may be disrupted by accompanying acidosis. The use of metabolite/creatinine ratios as a measure of metabolite excretion rates during metabolic decompensation whilst qualitatively sound may need a re-appraisal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1709598     DOI: 10.1016/0009-8981(90)90135-f

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Oral vitamin B12 treatment of cobalamin-responsive methylmalonic aciduria.

Authors:  T K Ninan; H Thom; G Russell
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid.

Authors:  Marlene Marisol Perales-Quintana; Alma L Saucedo; Juan Ricardo Lucio-Gutiérrez; Noemí Waksman; Gabriela Alarcon-Galvan; Gustavo Govea-Torres; Concepcion Sanchez-Martinez; Edelmiro Pérez-Rodríguez; Francisco J Guzman-de la Garza; Paula Cordero-Pérez
Journal:  PeerJ       Date:  2019-06-21       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.